![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
WJ Wojcik and NH Neff
Baclofen and gamma-aminobutyric acid (GABA) are shown to inhibit basal adenylate cyclase activity in brain of rat. The response is mediated through the GABAB receptor, and the rank order of potency for agonists is (-)-baclofen (EC50 = 4 microM) greater than GABA (EC50 = 17 microM) greater than muscimol greater than (+)-baclofen. GABAA agonists are not effective inhibitors of cyclase activity. The response is bicuculline- insensitive, and diazepam does not modify the GABA or (-)-baclofen inhibition of adenylate cyclase. Studies with neurologically mutant mice correlated a loss in GABAB receptor-mediated inhibition of cyclase with a loss in cerebellar granule cells. Thus, the GABAB receptor is negatively coupled to adenylate cyclase in various brain areas, and, in the cerebellum, data suggest a granule cell localization of this activity.
This article has been cited by other articles:
|
|
 |
|
  M. T. Ghorbel, K. G. Becker, and J. M. Henley Profile of changes in gene expression in cultured hippocampal neurones evoked by the GABAB receptor agonist baclofen Physiol Genomics, June 16, 2005; 22(1): 93 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. A. Frere and A. Luthi Pacemaker channels in mouse thalamocortical neurones are regulated by distinct pathways of cAMP synthesis J. Physiol., January 1, 2004; 554(1): 111 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Bowery, B. Bettler, W. Froestl, J. P. Gallagher, F. Marshall, M. Raiteri, T. I. Bonner, and S. J. Enna International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function Pharmacol. Rev., June 1, 2002; 54(2): 247 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Enna A GABAB Mystery: The Search for Pharmacologically Distinct GABAB Receptors Mol. Interv., October 1, 2001; 1(4): 208 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kuner, G. Köhr, S. Grünewald, G. Eisenhardt, A. Bach, and H. Kornau Role of Heteromer Formation in GABAB Receptor Function Science, January 1, 1999; 283(5398): 74 - 77. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Reid, T.-Z. Guo, M. F. Davies, and M. Maze Nifedipine, an L-type Calcium Channel Blocker, Restores the Hypnotic Response in Rats Made Tolerant to the Alpha-2 Adrenergic Agonist Dexmedetomidine J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 993 - 999. [Abstract] [Full Text]
|
|
|
|
|
|
R Andrade, R. Malenka, and R. Nicoll A G protein couples serotonin and GABAB receptors to the same channels in hippocampus Science, December 5, 1986; 234(4781): 1261 - 1265. [Abstract] [PDF]
|
|
|
|
 |
|
 R. B. Nehring, H. P. M. Horikawa, O. El Far, M. Kneussel, J. H. Brandstatter, S. Stamm, E. Wischmeyer, H. Betz, and A. Karschin The Metabotropic GABAB Receptor Directly Interacts with the Activating Transcription Factor 4 J. Biol. Chem., November 3, 2000; 275(45): 35185 - 35191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Lacor, D. R. Grayson, J. Auta, I. Sugaya, E. Costa, and A. Guidotti Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation PNAS, March 28, 2000; 97(7): 3556 - 3561. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
